Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance).

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance). J Thorac Oncol. 2017 05; 12(5):843-849.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Anemia
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Carcinoma, Non-Small-Cell Lung
Disease-Free Survival
Double-Blind Method
Drug Eruptions
Fatigue
Female
Humans
Hypertension
Indoles
Intention to Treat Analysis
Lung Neoplasms
Maintenance Chemotherapy
Male
Middle Aged
Mucositis
Neoplasm Staging
Neutropenia
Platinum Compounds
Pyrroles
Quality of Life
Survival Rate
Thrombocytopenia

authors with profiles

Everett E. Vokes
Olwen Hahn